Hanrahan, E., Ryan, A., Mann, H., Kennedy, S., Langmuir, P., Natale, R., . . . Heymach, J. (2009). Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
Chicagoスタイル(17版)引用形式Hanrahan, E., A. Ryan, H. Mann, S. Kennedy, P. Langmuir, R. Natale, R. Herbst, B. Johnson, , J. Heymach. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.
MLA(9版)引用形式Hanrahan, E., et al. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.
警告: この引用は必ずしも正確ではありません.